Europe Non-Invasive Aesthetic Treatment Market is expected to reach US$ 5,830.17 million by 2028

The injectables segment by procedure is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Procedure, End User and Country.” The Europe non-invasive aesthetic treatment market is expected to reach US$ 5,830.17 million in 2028 from US$ 2,337.83 million in 2021, it is estimated to grow at a CAGR of 13.9% from 2021 to 2028. The report highlights trends prevailing in the Europe non-invasive aesthetic treatment market and the factors driving market along with those that act as hindrances.

The Europe non-invasive aesthetic treatment market based on the procedure was segmented into injectables, skin rejuvenation, and others. In 2020, the injectables segment held the largest share of the market, and same segment is expected to grow at the fastest rate during the coming years.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Moreover, non-invasive treatments are gaining traction due to high preference for less downtime post treatment. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people. For example, the government in England began a campaign in 2019 on botched cosmetic procedures and their influence on a person’s physical and mental health. Therefore, the growing awareness regarding non-invasive aesthetic treatment procedures is boosting the growth of the Europe non-invasive aesthetic treatment market. Several manufacturers are working on advanced non-invasive aesthetic treatment products. Therefore, the availability of user-friendly, technologically advanced non-invasive aesthetic treatment products is fuelling the market growth.

The COVID-19 pandemic has slightly hindered the medical device industry in Europe. Various companies have shut down their productions; hence, they are unable to meet the rising demand. The routine health care services have remained suspended. On the other hand, the number of COVID-19 confirmed cases has grown significantly, and it has raised the question regarding safety from the aesthetic treatments done by lasers and micro-needling. Thus, aesthetic services have been shut down in European countries. Hence, it is expected that the negative impact on the Europe non-invasive aesthetic treatment market will continue in the following a few years.

Galderma, Alma Lasers, Merz Pharma, Bausch Health Companies Inc., Cutera Inc., AbbVie Inc., Candela Medical and Johnson and Johnson Services, Inc. are among the leading companies operating in the Europe non-invasive aesthetic treatment market.

The growth of the market is attributed to a few key driving factors such as surging awareness about cosmetic procedures among consumers and availability of technologically advanced products. However, clinical risks and complications associated with medical aesthetic procedures are hindering the market growth.

The report segments in Europe Non-Invasive Aesthetic Treatment Market as follows:

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By End User

• Hospitals
• Clinics and Medical Spas
• Others

By Country

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe